Literature DB >> 35832108

Improvement in Long-COVID Symptoms Using Acupuncture: A Case Study.

Michael Hollifield1,2, Karen Cocozza3, Teresa Calloway1, Jennifer Lai1, Brianna Caicedo1, Kala Carrick1, Ruth Alpert1, An-Fu Hsiao1,4.   

Abstract

Background: The long-COVID syndrome (LCS), defined by residual symptoms from acute COVID-19 for <60 days, affects about one-third of all COVID survivors and is an emerging public health challenge. Empirical data about the range of symptoms or the utility of acupuncture alone for the LCS are very limited. Case: This observational case study of a 46-year-old male with LCS was conducted to preliminarily define the range of symptoms, a Traditional Chinese Medicine (TCM) diagnostic structure, and evaluate the potential utility of prescribed acupuncture for LCS.
Results: The primary TCM diagnostic patterns from this patient's LCS presentation included Lung Qi and Yin Deficiency, Qi and Blood Stagnation, and Spleen Qi Deficiency with dampness. Acupuncture for this patient was associated with reduced symptoms and signs of LCS.
Conclusion: A preliminary TCM diagnostic structure for LCS was defined. Acupuncture appears to have been helpful for a patient with LCS. Further research is needed to demonstrate the efficacy of acupuncture and/or other TCM modalities for LCS. Copyright 2022, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  COVID-19; acupuncture; long-COVID syndrome; postviral treatment; tongue assessment

Year:  2022        PMID: 35832108      PMCID: PMC9248334          DOI: 10.1089/acu.2021.0088

Source DB:  PubMed          Journal:  Med Acupunct        ISSN: 1933-6586


  14 in total

Review 1.  Therapeutic modulation of the psychoneuroimmune system by medical acupuncture creates enhanced feelings of well-being.

Authors:  Allan Walling
Journal:  J Am Acad Nurse Pract       Date:  2006-04

2.  Somatotopic Organization and Intensity Dependence in Driving Distinct NPY-Expressing Sympathetic Pathways by Electroacupuncture.

Authors:  Shenbin Liu; Zhi-Fu Wang; Yang-Shuai Su; Russell S Ray; Xiang-Hong Jing; Yan-Qing Wang; Qiufu Ma
Journal:  Neuron       Date:  2020-08-12       Impact factor: 17.173

Review 3.  Post-acute COVID-19 syndrome.

Authors:  Ani Nalbandian; Kartik Sehgal; Aakriti Gupta; Mahesh V Madhavan; Claire McGroder; Jacob S Stevens; Joshua R Cook; Anna S Nordvig; Daniel Shalev; Tejasav S Sehrawat; Neha Ahluwalia; Behnood Bikdeli; Donald Dietz; Caroline Der-Nigoghossian; Nadia Liyanage-Don; Gregg F Rosner; Elana J Bernstein; Sumit Mohan; Akinpelumi A Beckley; David S Seres; Toni K Choueiri; Nir Uriel; John C Ausiello; Domenico Accili; Daniel E Freedberg; Matthew Baldwin; Allan Schwartz; Daniel Brodie; Christine Kim Garcia; Mitchell S V Elkind; Jean M Connors; John P Bilezikian; Donald W Landry; Elaine Y Wan
Journal:  Nat Med       Date:  2021-03-22       Impact factor: 53.440

4.  Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?

Authors:  Yvonne M J Goërtz; Maarten Van Herck; Jeannet M Delbressine; Anouk W Vaes; Roy Meys; Felipe V C Machado; Sarah Houben-Wilke; Chris Burtin; Rein Posthuma; Frits M E Franssen; Nicole van Loon; Bita Hajian; Yvonne Spies; Herman Vijlbrief; Alex J van 't Hul; Daisy J A Janssen; Martijn A Spruit
Journal:  ERJ Open Res       Date:  2020-10-26

Review 5.  A Review of Persistent Post-COVID Syndrome (PPCS).

Authors:  Bryan Oronsky; Christopher Larson; Terese C Hammond; Arnold Oronsky; Santosh Kesari; Michelle Lybeck; Tony R Reid
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-20       Impact factor: 10.817

6.  The impact of Post-COVID-Syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany.

Authors:  Christina Lemhöfer; Christian Sturm; Dana Loudovici-Krug; Norman Best; Christoph Gutenbrunner
Journal:  J Occup Med Toxicol       Date:  2021-10-07       Impact factor: 2.646

7.  Traditional chinese medicine for chronic fatigue syndrome.

Authors:  Rui Chen; Junji Moriya; Jun-Ichi Yamakawa; Takashi Takahashi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

8.  Persistent Symptoms in Patients After Acute COVID-19.

Authors:  Angelo Carfì; Roberto Bernabei; Francesco Landi
Journal:  JAMA       Date:  2020-08-11       Impact factor: 56.272

9.  Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.

Authors:  Mark W Tenforde; Sara S Kim; Christopher J Lindsell; Erica Billig Rose; Nathan I Shapiro; D Clark Files; Kevin W Gibbs; Heidi L Erickson; Jay S Steingrub; Howard A Smithline; Michelle N Gong; Michael S Aboodi; Matthew C Exline; Daniel J Henning; Jennifer G Wilson; Akram Khan; Nida Qadir; Samuel M Brown; Ithan D Peltan; Todd W Rice; David N Hager; Adit A Ginde; William B Stubblefield; Manish M Patel; Wesley H Self; Leora R Feldstein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-31       Impact factor: 17.586

10.  Long COVID and chronic COVID syndromes.

Authors:  Stephen Halpin; Rory O'Connor; Manoj Sivan
Journal:  J Med Virol       Date:  2020-10-30       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.